Revenue Downgrade: Here's What Analysts Forecast For I.CO.P. S.p.A. Società Benefit (BIT:ICOP)

Today is shaping up negative for I.CO.P. S.p.A. Società Benefit (BIT:ICOP) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Following the downgrade, the latest consensus from I.CO.P.. Società Benefit's dual analysts is for revenues of €444m in 2025, which would reflect a substantial 131% improvement in sales compared to the last 12 months. Per-share earnings are expected to leap 54% to €1.03. Before this latest update, the analysts had been forecasting revenues of €498m and earnings per share (EPS) of €1.03 in 2025. Indeed we can see that the consensus opinion has undergone some fundamental changes following the recent consensus updates, with a measurable cut to revenues and some minor tweaks to earnings numbers.

View our latest analysis for I.CO.P.. Società Benefit

the analysts have also increased their price target 12% to €21.00, clearly signalling that lower revenue forecasts this year are not expected to have a material impact on I.CO.P.. Società Benefit's valuation.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analysts are definitely expecting I.CO.P.. Società Benefit's growth to accelerate, with the forecast 131% annualised growth to the end of 2025 ranking favourably alongside historical growth of 68% per annum over the past year. Compare this with other companies in the same industry, which are forecast to grow their revenue 9.3% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect I.CO.P.. Società Benefit to grow faster than the wider industry.

The Bottom Line

The most obvious conclusion from this consensus update is that there's been no major change in the business' prospects in recent times, with analysts holding earnings per share steady, in line with previous estimates. While analysts did downgrade their revenue estimates, these forecasts still imply revenues will perform better than the wider market. There was also a nice increase in the price target, with analysts apparently feeling that the intrinsic value of the business is improving. Often, one downgrade can set off a daisy-chain of cuts, especially if an industry is in decline. So we wouldn't be surprised if the market became a lot more cautious on I.CO.P.. Società Benefit after today.

Still, the long-term prospects of the business are much more relevant than next year's earnings. We have analyst estimates for I.CO.P.. Società Benefit going out as far as 2027, and you can see them free on our platform here.

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.